OncoMed Pharmaceuticals Inc Accumulated Other Comprehensive Income
OncoMed Pharmaceuticals Inc had Accumulated Other Comprehensive Income of -$29.00 thousand as of 2018-12-31, per its 10-K filed 2019-03-07.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2019-03-07
- 2018-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$29.00K.
- 2018-09-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$62.00K.
- 2018-06-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$57.00K.
- 2018-03-31: Accumulated Other Comprehensive Income (Loss), Net of Tax $156.00K.
| Period end | Accumulated Other Comprehensive Income (Loss), Net of Tax |
|---|---|
| 2018-12-31 | -$29.00K 10-K · filed 2019-03-07 |
| 2018-09-30 | -$62.00K 10-Q · filed 2018-11-01 |
| 2018-06-30 | -$57.00K 10-Q · filed 2018-08-02 |
| 2018-03-31 | $156.00K 10-Q · filed 2018-05-08 |
| 2017-12-31 | $289.00K 10-K · filed 2019-03-07 |
| 2017-09-30 | $175.00K 10-Q · filed 2017-11-02 |
| 2017-06-30 | $272.00K 10-Q · filed 2017-08-02 |
| 2017-03-31 | $268.00K 10-Q · filed 2017-05-08 |
| 2016-12-31 | $260.00K 10-K · filed 2018-03-09 |
| 2016-09-30 | $191.00K 10-Q · filed 2016-11-01 |
| 2016-06-30 | $162.00K 10-Q · filed 2016-08-09 |
| 2016-03-31 | $135.00K 10-Q · filed 2016-05-05 |
| 2015-12-31 | $20.00K 10-K · filed 2017-03-09 |
| 2015-09-30 | $124.00K 10-Q · filed 2015-11-05 |
| 2015-06-30 | $104.00K 10-Q · filed 2015-08-10 |
| 2015-03-31 | $75.00K 10-Q · filed 2015-05-07 |
| 2014-12-31 | -$17.00K 10-K · filed 2016-03-10 |
| 2014-09-30 | $34.00K 10-Q · filed 2014-11-04 |
| 2014-06-30 | -$11.00K 10-Q · filed 2014-08-07 |
| 2014-03-31 | -$29.00K 10-Q · filed 2014-05-08 |
| 2013-12-31 | $14.00K 10-K · filed 2015-03-12 |
| 2013-09-30 | $17.00K 10-Q · filed 2013-11-13 |
| 2013-06-30 | $15.00K 10-Q · filed 2013-09-03 |
| 2012-12-31 | $15.00K 10-K · filed 2014-03-18 |